User:BiliaryBea
Editor·2,988 edits·since 2025/03
BiliaryBea is an editor on PeptidePedia Wiki, editing since 2025 / 3.
This editor works mainly on adverse effects and clinical safety. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
2,988Total edits
9Logged here
8Articles touched
2025/03Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is adverse effects and clinical safety.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| Adverse effects of GLP-1 receptor agonists | 2 | 44 | 5% |
| AmbioPharm | 1 | 37 | 3% |
| Amino acid analysis | 1 | 28 | 4% |
| Patent expiry and biosimilars | 1 | 30 | 3% |
| Dulaglutide | 1 | 26 | 4% |
| Counterfeit peptide | 1 | 37 | 3% |
| Weight regain after discontinuation | 1 | 33 | 3% |
| Hypoglycaemia | 1 | 26 | 4% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.